RollingStone Co., Ltd. (KOSDAQ:214610)

Market Cap	29.61B
Revenue (ttm)	891.68M
Net Income (ttm)	-21.07B
Shares Out	8.38M
EPS (ttm)	-345.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,852
Average Volume	15,107
Open	3,700.00
Previous Close	3,605.00
Day's Range	3,460.00 - 3,700.00
52-Week Range	3,250.00 - 13,250.00
Beta	0.26
RSI	41.26
Earnings Date	Mar 20, 2026

About RollingStone

RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; Veri-Q PCR 316 PB products; and LabChip, sample tube, and pre-filtering column products. It also provides b...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 48
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214610

Financial Performance

In 2024, RollingStone's revenue was 4.64 billion, a decrease of -13.55% compared to the previous year's 5.37 billion. Losses were -30.85 billion, 19.7% more than in 2023.